Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.920
-0.080 (-2.67%)
At close: Jul 11, 2025, 4:00 PM
2.940
+0.020 (0.68%)
After-hours: Jul 11, 2025, 7:06 PM EDT
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $111.87 million as of July 11, 2025. Its market cap has decreased by -54.37% in one year.
Market Cap
111.87M
Enterprise Value
78.43M
1-Year Change
-54.37%
Ranking
Category
Stock Price
$2.92
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has decreased from $197.44M to $111.87M, a decrease of -43.34%. That is a compound annual growth rate of -10.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 111.87M | -26.43% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | 261.96M | 32.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |